Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim vs Filgrastim for PBPC Mobilisation in NHL
NCT00117455Phase 2Completed
- Sponsor
- Amgen
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of pegfilgrastim in Non-Hodgkin lymphoma (NHL), sponsored by Amgen. Status: completed.
02
Drugs
pegfilgrastim
03
Conditions
Non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00117455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117455.